デフォルト表紙
市場調査レポート
商品コード
1611203

遺伝子検査の市場規模、シェア、動向分析レポート:技術別、用途別、製品別、チャネル別、最終用途別、地域別、およびセグメント別動向:2025年~2030年

Genetic Testing Market Size, Share & Trends Analysis Report By Technology (NGS, PCR-based Testing, Array Technology), By Application, By Product, By Channel (Online, Offline), By End-use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
遺伝子検査の市場規模、シェア、動向分析レポート:技術別、用途別、製品別、チャネル別、最終用途別、地域別、およびセグメント別動向:2025年~2030年
出版日: 2024年11月25日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の遺伝子検査市場規模は2030年までに392億5,000万米ドルに達すると予測されています。

同市場は2025~2030年にかけてCAGR 22.5%で成長すると予測されています。遺伝子検査産業の成長は、遺伝子疾患の有病率の上昇、研究開発への投資の増加、著名な市場参入企業のイニシアチブが主要要因です。さらに、個別化医療を重視する傾向が強まっていることも、消費者直接遺伝子検査産業に好影響を与えそうです。

さらに、政府当局は遺伝子研究を奨励し統合するための国家プログラムの実施に注力しています。こうした国の遺伝子研究プログラムの1次調査の目標は、多様な民族に等しく適した個別化治療計画や医薬品を開発する目的で、データ収集への投資を増やすことです。この目標を達成するためには、遺伝子検査に対する認識と受容が重要な役割を果たすと期待されています。

遺伝子検査は、がんなどの慢性疾患の診断やモニタリングに大きく応用されています。様々な形態のがんの発生が増加していること、検査手法の使用により比較的高い寛解率が得られることから、予測期間を通じて個別化診断セグメントで最も速い成長率で成長すると予想されます。加えて、各社は効率的ながん診断のために先進的なインフォマティクスツールの統合を共同で進めており、これが同セグメントの成長にさらに寄与しています。

例えば、2021年2月、TempusはPrecision Health Informaticsと提携し、がん領域におけるプレシジョン・メディシン(PM)の進展を加速させています。プレシジョンヘルスインフォマティクスは、テンポスのゲノム配列分析能力とAI対応プラットフォームを活用し、効率的な個別化患者ケアと臨床研究プログラムを構築しました。

それとともに、さまざまな新興国の政府は、検査を実施するためのインフラを確立するためのイニシアチブをとっています。例えば、2021年にはMoh.Bin Rashid University of Medicine and Health SciencesとA.J. Children's Specialty Hospital(AJCH)は、Al Jalila Genomics Centerを通じて、新しくユニークな科学的・医療的学際的環境を構築するために協力しました。さらに、包括的なアカデミックヘルスシステムの一部としてゲノム・ディスカバリー・センターが開発されることで、ゲノミクスと遺伝子ディスカバリーの進歩が可能になります。

ゲノムデータは、PM、診断、トキシコゲノミクスなど、さまざまな目的に利用することができます。しかし、研究で得られた膨大なデータの分析は重要な課題です。技術的な向上により、機器を使って評価を下すことが可能になった例もあります。しかし、そのプロセスは依然として、担当する専門家の認識に大きく依存しています。したがって、熟練した専門家の必要性が新興国市場の成長を妨げる可能性が高いです。

遺伝子検査市場レポートハイライト

  • 技術別では、次世代シーケンシングは比較的成熟したセグメントであり、2024年には遺伝子検査産業の最大シェアを占めました。これは、がんの個別化治療法を開発するために社内に研究ステーションを設置する製薬企業やバイオテクノロジー企業が増加しているためです。
  • 用途別では、新興市場における遺伝性疾患の増加に起因して、遺伝的先祖スクリーニングセグメントが2024年の市場シェアの大半を占めました。
  • 製品別では、臨床診断の技術的に先進的ワークフローを採用するために政府や国際機関による投資が増加していることから、消耗品が2024年に最大シェアを占めると予想されます。
  • チャネル別では、ShareDNAのような検査結果や解釈に関する関連情報を提供するスマートフォンアプリケーションの利用が増加していることから、オンラインが予測期間中に最も急成長すると予想されます。
  • 最終用途別では、診断ラボが最も急成長すると予測されます。この成長の背景には、個別化された治療法の開発を目的とした企業と検査機関の共同研究や戦略的パートナーシップの増加があります。
  • 北米は遺伝子検査産業において圧倒的な地域的地位を占めており、市場全体の45.38%を占めています。慢性疾患や感染症などの疾病発生率の増加が、この地域のELISA分析装置市場への参入を促しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 遺伝子検査市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 遺伝子検査市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 遺伝子検査市場:技術別、推定・動向分析

  • 技術市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 技術による世界の遺伝子検査市場展望
  • 2018~2030年の市場規模と予測と動向分析
    • 次世代シーケンシング
    • アレイ技術
    • PCRベースの検査
    • FISH
    • その他

第5章 遺伝子検査市場:用途別、推定・動向分析

  • 用途市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 用途による世界の遺伝子検査市場展望
  • 2018~2030年の市場規模と予測と動向分析
    • 遺伝的先祖スクリーニング
    • 特性スクリーニング
    • 遺伝性疾患キャリアステータス
    • 新生児スクリーニング
    • 健康とウェルネス-素因/リスク/傾向

第6章 遺伝子検査市場:製品別、推定・動向分析

  • 製品市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 製品による世界の遺伝子検査市場展望
  • 2018~2030年の市場規模と予測と動向分析
    • 消耗品
    • 装置
    • ソフトウェアとサービス

第7章 遺伝子検査市場: チャネル別、推定・動向分析

  • チャネル市場シェア、2024年と2030年
  • セグメントダッシュボード
  • チャネルによる世界の遺伝子検査市場展望
  • 2018~2030年の市場規模と予測と動向分析
    • オンライン
    • オフライン

第8章 遺伝子検査市場:最終用途別、推定・動向分析

  • 最終用途市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 最終用途による世界の遺伝子検査市場展望
  • 2018~2030年の市場規模と予測と動向分析
    • 病院・クリニック
    • 診断ラボ
    • その他

第9章 遺伝子検査市場:地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模と予測動向分析、2018~2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
    • 24 genetics
    • Circle DNA
    • TellmeGen
    • 23andme
    • AncestryDNA
    • MyDNA
    • Igenomix
    • Myriad Genetics, Inc
    • Illumina, Inc.
    • MyHeritage Ltd.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Global Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 7 Global Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Genetic Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Genetic Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 11 North America Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 North America Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 14 North America Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.S. Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 19 U.S. Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 21 Canada Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 Canada Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Canada Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 24 Canada Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Genetic Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 Europe Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Europe Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Europe Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 30 Europe Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Germany Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 34 Germany Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 35 Germany Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 UK Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 UK Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 UK Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 UK Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 40 UK Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 France Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 42 France Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 France Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 France Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 45 France Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Italy Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Italy Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Italy Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Italy Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 50 Italy Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Spain Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 52 Spain Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Spain Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Spain Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 55 Spain Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Denmark Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Denmark Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Denmark Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 60 Denmark Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Sweden Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Sweden Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 63 Sweden Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Sweden Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 65 Sweden Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Norway Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 67 Norway Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Norway Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Norway Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 70 Norway Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Genetic Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 China Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 China Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 China Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 China Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 81 China Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Japan Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Japan Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Japan Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Japan Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 86 Japan Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 India Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 India Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 India Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 India Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 91 India Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 South Korea Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 South Korea Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 South Korea Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 96 South Korea Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Australia Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 Australia Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Australia Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 100 Australia Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 101 Australia Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 102 Thailand Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 Thailand Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 105 Thailand Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 106 Thailand Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Latin America Genetic Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 110 Latin America Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 Latin America Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 112 Latin America Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113 Brazil Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Brazil Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 Brazil Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 117 Brazil Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Mexico Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 119 Mexico Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 Mexico Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 121 Mexico Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 122 Mexico Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 125 Argentina Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 Argentina Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 127 Argentina Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Genetic Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 136 South Africa Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 South Africa Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 138 South Africa Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 145 UAE Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 146 UAE Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 UAE Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 148 UAE Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Genetic Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Genetic Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Genetic Testing Market, by Channel, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Genetic Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Genetic Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Genetic Testing Market, Technology Movement Analysis
  • Fig. 16 Global Genetic Testing Market, for Next Generation Sequencing, 2018 - 2030 (USD Million)
  • Fig. 17 Global Genetic Testing Market, for Array Technology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Genetic Testing Market, for PCR - based Testing, 2018 - 2030 (USD Million)
  • Fig. 19 Global Genetic Testing Market, for FISH, 2018 - 2030 (USD Million)
  • Fig. 20 Global Genetic Testing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Genetic Testing Market, Application Movement Analysis
  • Fig. 22 Global Genetic Testing Market, for Ancestry & Ethnicity, 2018 - 2030 (USD Million)
  • Fig. 23 Global Genetic Testing Market, for Traits Screening, 2018 - 2030 (USD Million)
  • Fig. 24 Global Genetic Testing Market, for Genetic Disease Carrier Status, 2018
  • Fig. 25 Global Genetic Testing Market, for New Baby Screening, 2018 - 2030 (USD Million)
  • Fig. 26 Global Genetic Testing Market, for Health and Wellness - Predisposition
  • Fig. 27 Global Genetic Testing Market, Product Movement Analysis
  • Fig. 28 Global Genetic Testing Market, for Consumables, Movement Analysis
  • Fig. 29 Global Genetic Testing Market, for Equipment, 2018 - 2030 (USD Million)
  • Fig. 30 Global Genetic Testing Market, for Software & Services, 2018 - 2030 (USD Million)
  • Fig. 31 Global Genetic Testing Market, Channel Movement Analysis
  • Fig. 32 Global Genetic Testing Market, for Online, 2018 - 2030 (USD Million)
  • Fig. 33 Global Genetic Testing Market, for Offline, 2018 - 2030 (USD Million)
  • Fig. 34 Global Genetic Testing Market, End Use Movement Analysis
  • Fig. 35 Global Genetic Testing Market, for Hospitals & Clinics, 2018 - 2030 (USD Million)
  • Fig. 36 Global Genetic Testing Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 37 Global Genetic Testing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 Regional Outlook, 2024 & 2030
  • Fig. 40 Global Genetic Testing Market, Region Movement Analysis
  • Fig. 41 North America Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.K. Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 France Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 China Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 India Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 67 UAE Genetic Testing Market, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait Genetic Testing Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-040-3

Genetic Testing Market Growth & Trends:

The global genetic testing market size is anticipated to reach USD 39.25 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 22.5% from 2025 to 2030. The growth of the genetic testing industry is majorly attributed to the rising prevalence of genetic conditions, increasing investments in R&D, and initiatives by prominent market players. Moreover, increasing emphasis on personalized medicines is also likely to have a positive impact on the direct-to-consumer genetic testing industry.

Furthermore, government authorities are focusing on implementing national programs to encourage and consolidate genetic research. The primary goal of these national genetic research programs is to increase their investments in the compilation of data with an aim to develop personalized treatment plans and medicines, suitable for diverse ethnicities equally. To achieve this goal, awareness and acceptance of genetic testing is expected to play a crucial role.

Genetic testing has major applications in the diagnosis and monitoring of chronic illnesses such as cancers. Owing to increasing incidences of various forms of cancers, and a relatively higher rate of remission provided by the use of testing methodologies, it is expected that this segment with grow at the fastest growth rate in the personalized diagnostics segment throughout the forecast period. In addition, companies are collaborating to integrate advanced informatics tools for efficient diagnosis of cancer which is further contributing to the segment growth.

For instance, in February 2021, Tempus entered in a collaboration with Precision Health Informatics for accelerating the advancement of Precision Medicine (PM) in oncology. Precision Health Informatics leveraged Tempus' genomic sequencing capabilities and AI-enabled platform to create an efficient personalized patient care and clinical research program.

Along with that, governments of various emerging countries are taking initiatives to establish an infrastructure for conducting testing. For instance, in 2021, Moh. Bin Rashid University of Medicine and Health Sciences and A.J. Children's Specialty Hospital (AJCH) collaborated to establish a new & unique scientific and medical interdisciplinary environment through the Al Jalila Genomics Center. Furthermore, the development of the Center for Genomic Discovery as part of the comprehensive academic health system will allow for advancements in genomics and gene discovery.

Genomic data can be used for a variety of purposes, including PM, diagnosis, and toxicogenomics. However, the analysis of massive amounts of data produced in studies is a significant challenge. In some instances, technical improvements have made it possible for the equipment to be used to give an assessment. Although, the process still relies heavily on the perception of the professional in-charge. Hence, the need for skilled professionals is likely to hamper the growth of the market in developing countries.

Genetic Testing Market Report Highlights:

  • By technology, Next-generation sequencing is a relatively more mature segment and held the largest genetic testing industry share in 2024, Owing to the increasing number of pharmaceutical and biotechnology companies establishing in-house research stations for developing a personalized treatment for cancers
  • By application, the genetic ancestry screening segment captured the majority of the market share in 2024, owing to the increasing genetic disorders in emerging markets
  • By product,consumables are expected to capture the largest share of the market in 2024, owing to the increasing investment by governments and international bodies to adopt a technologically advanced workflow of clinical diagnostics
  • By channel,online is expected to witness the fastest growth during the forecast period, owing to the increasing use of smartphone applications, such as ShareDNA, that offer relevant information about test results and interpretation
  • By end-user, diagnostic laboratories are anticipated to be the fastest-growing segment. This growth can be attributed to the increasing collaborations and strategic partnerships between corporations and laboratories to develop personalized therapeutic formations
  • North America has a dominant regional position in the genetic testing industry with 45.38% share of the overall market. The increasing incidence of diseases, such as chronic and infectious diseases, is encouraging companies to enter the regional ELISA analyzers market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. Product
    • 1.2.4. Channel
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. Product outlook
    • 2.2.4. Channel outlook
    • 2.2.5. End Use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Genetic Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological Advancements in Diagnostic Testing
      • 3.2.1.2. Growing Burden of Chronic and Infection Diseases
      • 3.2.1.3. Rising Awareness and Demand for Personalized Medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Required Skilled Labors
  • 3.3. Genetic Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Genetic Testing Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Genetic Testing Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Next-Generation Sequencing
      • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD million)
    • 4.4.2. Array Technology
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. PCR - Based Testing
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. FISH
      • 4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Genetic Testing Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Genetic Testing Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Ancestry & Ethnicity
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD million)
    • 5.4.2. Traits Screening
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Genetic Disease Carrier Status
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. New Baby Screening
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.5. Health and Wellness - Predisposition/ Risk/tendency
      • 5.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Genetic Testing Market: Product Estimates & Trend Analysis

  • 6.1. Product Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Genetic Testing Market by Product Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Consumables
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD million)
    • 6.4.2. Equipment
      • 6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Software & Services
      • 6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Genetic Testing Market: Channel Estimates & Trend Analysis

  • 7.1. Channel Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Genetic Testing Market by Channel Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Online
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD million)
    • 7.4.2. Offline
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Genetic Testing Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2024 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Genetic Testing Market by End Use Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Hospitals & Clinics
      • 8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD million)
    • 8.4.2. Diagnostic Laboratories
      • 8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Others
      • 8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Genetic Testing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.2. Argentina
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2024
    • 10.3.4. 24 genetics
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Circle DNA
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. TellmeGen
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. 23andme
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. AncestryDNA
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. MyDNA
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Igenomix
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Myriad Genetics, Inc
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Illumina, Inc.
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. MyHeritage Ltd.
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives